No. I don't blame Lederle for not solving the issue as the approach we used did not exist back in the 1980s. There have been huge advances in drug formulation over the last 40 years.
- Forums
- ASX - By Stock
- Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
No. I don't blame Lederle for not solving the issue as the...
-
-
- There are more pages in this discussion • 350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.42 |
Change
0.010(0.71%) |
Mkt cap ! $247.0M |
Open | High | Low | Value | Volume |
$1.45 | $1.46 | $1.41 | $82.22K | 57.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 4771 | $1.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.42 | 1600 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7 | 1.430 |
1 | 534 | 1.425 |
2 | 6455 | 1.420 |
4 | 1288 | 1.415 |
1 | 534 | 1.410 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 4216 | 4 |
1.460 | 6909 | 2 |
1.465 | 1000 | 1 |
1.475 | 1000 | 1 |
1.485 | 7734 | 2 |
Last trade - 13.08pm 07/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |